JPMA on Alert for IRA’s Drug Pricing Provisions, Boosting Cooperation with PhRMA

JPMA Managing Director Sachiko Nakagawa The Japan Pharmaceutical Manufacturers Association (JPMA) is strengthening its collaboration with the Pharmaceutical Research and Manufacturers of America (PhRMA) over the Medicare drug price negotiation plan stipulated under the Inflation Reduction Act (IRA). The trade...read more